Sana Biotechnology SANA
NASDAQ SANA
$2.88 -0.03 (-0.86%)
As of: Sep 30, 2026 · 10:25 AM EDT

Sana Biotechnology (SANA) Total Current Liabilities (2020 - 2026)

Updated

Sana Biotechnology (SANA) posted Total Current Liabilities of $123.75 million for Q2 2026, up 270.0% from $33.44 million a year earlier and up 43.5% from the prior quarter.

Analysis

Sana Biotechnology (SANA) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Sana Biotechnology's Total Current Liabilities came in at $78.73 million, up 73.3% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 20.1% (FY2020 to FY2025).
  • In prior years, Sana Biotechnology's Total Current Liabilities was $45.43 million in FY2024 (-29.5%), $64.49 million in FY2023 (-42.2%), $111.5 million in FY2022 (+12.4%) and $99.24 million in FY2021 (+215.5%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q4 2020.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last three quarters, with growth averaging 43.6% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2026, with growth of 270.0%; the weakest was Q2 2024, with a decline of 54.8%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $86.27 million (Q1 2026), $78.73 million (Q4 2025) and $35.51 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Sana Biotechnology 876.97 Mn 876.97 Mn - 123.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 123.75 Mn
Mar 31, 2026 86.27 Mn
Dec 31, 2025 78.73 Mn
Sep 30, 2025 35.51 Mn
Jun 30, 2025 33.44 Mn
Mar 31, 2025 33.16 Mn
Dec 31, 2024 45.43 Mn
Sep 30, 2024 47.00 Mn
Jun 30, 2024 50.69 Mn
Mar 31, 2024 52.90 Mn
Dec 31, 2023 64.49 Mn
Sep 30, 2023 66.64 Mn
Jun 30, 2023 112.11 Mn
Mar 31, 2023 102.78 Mn
Dec 31, 2022 111.50 Mn
Sep 30, 2022 114.81 Mn
Jun 30, 2022 97.11 Mn
Mar 31, 2022 93.51 Mn
Dec 31, 2021 99.24 Mn
Sep 30, 2021 92.01 Mn
API Access

Sana Biotechnology Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SANA&period=max&api_key=YOUR_API_KEY